PHOENIX — The U.S. Food and Drug Administration has approved the first treatment designed to tackle postpartum depression, a potentially life-threatening condition that affects nearly 1 in 7 new mothers in America. However, the 60-hour intravenous drip will cost $20,000 to $35,000 and require a stay in a medical facility, and it’s unclear whether insurance […]